281 related articles for article (PubMed ID: 21992443)
21. Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an effective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer.
Murat FJ; Poissonnier L; Rabilloud M; Belot A; Bouvier R; Rouviere O; Chapelon JY; Gelet A
Eur Urol; 2009 Mar; 55(3):640-7. PubMed ID: 18508188
[TBL] [Abstract][Full Text] [Related]
22. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry.
Jones JS; Rewcastle JC; Donnelly BJ; Lugnani FM; Pisters LL; Katz AE
J Urol; 2008 Aug; 180(2):554-8. PubMed ID: 18550117
[TBL] [Abstract][Full Text] [Related]
23. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients.
Ismail M; Ahmed S; Kastner C; Davies J
BJU Int; 2007 Oct; 100(4):760-4. PubMed ID: 17662081
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of prostate specific antigen nadir after salvage cryotherapy.
Greene GF; Pisters LL; Scott SM; Von Eschenbach AC
J Urol; 1998 Jul; 160(1):86-90. PubMed ID: 9628611
[TBL] [Abstract][Full Text] [Related]
25. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
[TBL] [Abstract][Full Text] [Related]
26. Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
Siddiqui SA; Mynderse LA; Zincke H; Hoffmann NE; Lobo JR; Wilson TM; Kawashima A; Davis BJ; Blute ML
Urology; 2007 Jul; 70(1):80-5. PubMed ID: 17656213
[TBL] [Abstract][Full Text] [Related]
27. Salvage high-intensity focused ultrasound ablation for prostate cancer local recurrence after external-beam radiation therapy: prognostic value of prostate MRI.
Rouvière O; Sbihi L; Gelet A; Chapelon JY
Clin Radiol; 2013 Jul; 68(7):661-7. PubMed ID: 23485154
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience.
Lee B; Shinohara K; Weinberg V; Gottschalk AR; Pouliot J; Roach M; Hsu IC
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1106-12. PubMed ID: 17197119
[TBL] [Abstract][Full Text] [Related]
29. A prospective study of salvage high-intensity focused ultrasound for locally radiorecurrent prostate cancer: early results.
Berge V; Baco E; Karlsen SJ
Scand J Urol Nephrol; 2010 Sep; 44(4):223-7. PubMed ID: 20350272
[TBL] [Abstract][Full Text] [Related]
30. Prostate Specific Antigen Nadir of 0.1 or Less Is a Predictor of Treatment Success in Men Undergoing Salvage Whole Prostate Gland Cryoablation.
Nyame YA; Elshafei A; Greene DJ; Arora HC; Given RW; Tay KJ; Polascik TJ; Ross AE; Mouraviev VB; Lugnani F; Jones JS
J Endourol; 2017 May; 31(5):497-501. PubMed ID: 28437170
[TBL] [Abstract][Full Text] [Related]
31. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
[TBL] [Abstract][Full Text] [Related]
32. Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy.
Mouraviev V; Spiess PE; Jones JS
Eur Urol; 2012 Jun; 61(6):1204-11. PubMed ID: 22421081
[TBL] [Abstract][Full Text] [Related]
33. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
[TBL] [Abstract][Full Text] [Related]
34. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy.
Pisters LL; Perrotte P; Scott SM; Greene GF; von Eschenbach AC
J Clin Oncol; 1999 Aug; 17(8):2514-20. PubMed ID: 10561317
[TBL] [Abstract][Full Text] [Related]
35. Primary and salvage cryotherapy for prostate cancer.
Finley DS; Pouliot F; Miller DC; Belldegrun AS
Urol Clin North Am; 2010 Feb; 37(1):67-82, Table of Contents. PubMed ID: 20152521
[TBL] [Abstract][Full Text] [Related]
36. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease.
Cresswell J; Asterling S; Chaudhary M; Sheikh N; Greene D
BJU Int; 2006 May; 97(5):969-74. PubMed ID: 16643478
[TBL] [Abstract][Full Text] [Related]
37. Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy.
Izawa JI; Busby JE; Morganstern N; Vakar-Lopez F; Scott SM; Pisters LL
BJU Int; 2006 Sep; 98(3):554-8. PubMed ID: 16925753
[TBL] [Abstract][Full Text] [Related]
38. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience.
Ghafar MA; Johnson CW; De La Taille A; Benson MC; Bagiella E; Fatal M; Olsson CA; Katz AE
J Urol; 2001 Oct; 166(4):1333-7; discussion 1337-8. PubMed ID: 11547068
[TBL] [Abstract][Full Text] [Related]
39. Time to second prostate-specific antigen failure is a surrogate endpoint for prostate cancer death in a prospective trial of therapy for localized disease.
Zietman AL; Dallow KC; McManus PA; Heney NM; Shipley WU
Urology; 1996 Feb; 47(2):236-9. PubMed ID: 8607241
[TBL] [Abstract][Full Text] [Related]
40. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy.
Spiess PE; Lee AK; Leibovici D; Wang X; Do KA; Pisters LL
Cancer; 2006 Jul; 107(2):275-80. PubMed ID: 16770783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]